Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Prostatic Neoplasms × Testosterone × Clear all

Phase

Phase 2 7 Phase 1 2 Phase NA 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Neoplasms 1 Hypogonadism 1 Hot Flashes 1 Fatigue 1 Breast Neoplasms 1 Arthralgia 1

Interventions

Docetaxel 43 Prednisone 42 Radiotherapy 41 Goserelin 39 Leuprolide 37 bicalutamide 35 enzalutamide 25 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 24 Androgen Antagonists 22 Flutamide 19 Triptorelin Pamoate 17 apalutamide 15 Zoledronic Acid 12 Gonadotropin-Releasing Hormone 12 Abiraterone Acetate 12 gallium 68 PSMA-11 11 abiraterone 11 Radiation 11 Magnetic Resonance Spectroscopy 11 Prednisolone 9 Estramustine 8 Dexamethasone 8 Specimen Handling 7 Chemotherapy, Adjuvant 7 Buserelin 7 orteronel 6 luprolide acetate gel depot 6 darolutamide 6 cabazitaxel 6 Standard of Care 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04833426 2025-05-02

ENFORCE

Canisius-Wilhelmina Hospital

Phase 3 Recruiting

Hypogonadism, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡